article_metadata: Makoto Fujiwara Masaru Shimizu Tatsuya Okano Yuko Maejima Kenju Shimomura
article_metadata: 10.3389/fpubh.2023.1264056
article_metadata: Front Public Health
article_metadata: 2023 Dec 1:11:1264056.
article_metadata: sglt2 inhibitor diabetes insulin ipilimumab nivolumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/38106883/
article_metadata: Diabetes Mellitus, Type 1 / chemically induced Diabetes Mellitus, Type 1 / complications Diabetes Mellitus, Type 1 / drug therapy Diabetic Ketoacidosis / chemically induced Diabetic Ketoacidosis / drug therapy Lung Neoplasms / drug therapy Sodium-Glucose Transporter 2 Inhibitors / adverse effects
article_metadata: Diabetes Mellitus, Type 1 / chemically induced Diabetes Mellitus, Type 1 / complications Diabetes Mellitus, Type 1 / drug therapy Diabetic Ketoacidosis / chemically induced Diabetic Ketoacidosis / drug therapy Lung Neoplasms / drug therapy Sodium-Glucose Transporter 2 Inhibitors / adverse effects Systematic Review Case Reports Aged Humans Insulin / adverse effects Ipilimumab / therapeutic use Male Nivolumab / therapeutic use Nivolumab Sodium-Glucose Transporter 2 Inhibitors Ipilimumab Insulin
article_metadata: PMC10725247
article_metadata: 38106883
article_metadata: Successful treatment of nivolumab and ipilimumab triggered type 1 diabetes by using sodium-glucose transporter 2 inhibitor: a case report and systematic review
article_metadata: 2023